Position in NVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$160,356,033
+$14,024,676 QoQ
Shares Held
1,049,794
-1.1% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Chevy Chase Trust Holdings, LLC holds $1,529,841,397 across 12 Drug Manufacturers - General names. NVS ranks #4 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
397,885 | $365,962,685 | |
| 2 | JNJ |
Johnson & Johnson
|
1,305,710 | $319,167,751 | |
| 3 | ABBV |
AbbVie Inc.
|
904,397 | $196,697,302 | |
| 4 | NVS |
Novartis AG
This page
|
1,049,794 | $160,356,033 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,253,128 | $150,738,766 | |
| 6 | AMGN |
Amgen Inc
|
271,229 | $95,431,922 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
617,014 | $85,993,240 | |
| 8 | PFE |
Pfizer Inc
|
2,839,911 | $79,744,700 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $160,356,033 | 1,049,794 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $146,331,357 | 1,061,372 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $145,712,700 | 1,136,250 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $137,385,799 | 1,135,326 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $122,780,950 | 1,101,372 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $112,990,436 | 1,161,139 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $127,568,106 | 1,109,095 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $118,435,791 | 1,112,491 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $81,736,946 | 845,001 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $82,371,729 | 815,804 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $74,652,684 | 732,895 | Shares | Defined | 2023-10-23 | |
| 2023-06-30 | $73,727,671 | 730,628 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $63,370,152 | 688,806 | Shares | Defined | 2023-05-17 | |
| 2022-12-31 | $87,097,368 | 960,068 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $88,739,014 | 1,167,465 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $89,076,953 | 1,053,791 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $67,632,961 | 770,746 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $68,544,640 | 783,636 | Shares | Defined | 2022-01-31 | |
| 2021-09-30 | $63,008,300 | 770,461 | Shares | Defined | 2021-10-20 | |
| 2021-06-30 | $83,183,051 | 911,695 | Shares | Defined | 2021-07-20 | |
| 2021-03-31 | $74,119,195 | 867,094 | Shares | Defined | 2021-04-22 | |
| 2020-12-31 | $79,157,552 | 838,267 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $74,315,581 | 854,595 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $76,737,098 | 878,602 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $70,011,922 | 849,144 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||